Mr Brian Samas is an industrial scientist with over 22 years of experience at Pfizer Inc. Currently he holds a position of Sr. Principal Scientist in the Materials Science...
By Mr. Brian Samas, Pfizer Molecule XXIII is the most experimentally characterized crystal structure prediction (CSP) blind test molecule to date. Crystal structures of five polymorphs are presented with...
Richard is the Managing Director of Blaze Metrics, a company that designs, develops, and assists their customers to implement and apply cutting edge In-Process Microscopy, Spectroscopy, & Analytics from...
By Richard Becker, BlazeMetrics Process Analytical Technology (PAT) has dramatically expanded its capabilities over the last decade. Today’s PAT enables an in-depth understanding of process behavior on both macroscopic...
By Dr. Nima Yazdanpanah, Procegence Drug substance isolation by crystallization and filtration and spray drying are last stages of the drug substance manufacturing process, where critical quality attributes (CQAs)...
Dr. Michael Bellucci is a Senior Director at XtalPi, Inc. where he leads a research team that develops algorithm technologies for solid form development and risk assessment as well...
By Dr. Mike Bellucci, XtalPi Inc Crystallization is the most widely used separation and purification process in the pharmaceutical industry. The resulting crystal structure and corresponding crystal morphology isolated...
By Prof. Kevin Roberts, University Of Leeds The crystallization of organic materials provides a common, energy efficient methodology for the purification and isolation of high value compounds such as...
Kevin Roberts is currently Brotherton Professor of Chemical Engineering at the University of Leeds in the UK where he is also Director of the EPSRC’s Centre for Doctoral Training...
By Dr. Yuriy Abramov, Exe. Director of CC&DS, J-Star Research Regulatory expectations for control of impurities in new drugs have been established through ICH guidelines. The most efficient approach...
